IPO Boutique Research, Color & More Information for Subscribers
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Gevo Symbol: GEVO Price: Last trade $0.70 Trade Date: 6/10 Shares: TBD Underwriter(s) Cowen,Rodman & Renshaw, H.C. Wainwright Rating=Subscription Needed Company:[…]
It was a second-straight ‘lighter’ month in terms of quantity of IPOs that came to market as just 10 deals priced as compared to 19 deals in February 2014. There have been a total of 23 deals that have priced thus far in 2014 as compared to 36 at this same point a year ago.[…]
Thursday Pricings (Priced Friday AM) Bellerophon Therapeutics (Nasdaq: BLPH) – According to the underwriter, the deal was priced below range and up-sized. ‘BLPH’ prices 5 million shares at $12 and will debut today. Great AJax Corp (NYSE: AJX) – According to the underwriters, the deal was downsized and priced below the $15-$17 range. ‘AJX’ priced[…]
Tuesday Avenue Financial Holding (Nasdaq: AVNU) Wednesday Autogenomic (Nasdaq: AGMX) Sol-Wind Renewable Power (NYSE: SLWD) Thursday Inovalon Holdings (Nasdaq: INOV) Invitae Corporation (NYSE: NVTA) Friday Bellerpheron Therapeutics (Nasdaq: BLPH) Great AJax Corp (NYSE: AJX) Day-to-Day Infraredx (Nasdaq: REDX) Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) Eyegate Pharmaceuticals (Nasdaq: EYEG)